Program Overview
This CME program is derived from content presented at the 2017 Florida Society of Neurology Annual Meeting. Dr. Augusto Miravalle will review the pathophysiology of multiple sclerosis and how to make more effective treatment plans. Dr. Miravalle will analyze current and emerging clinical trial data for therapeutics in the treatment of multiple sclerosis. Finally, he will discuss how to implement patient education and shared decision making into patient-specific treatment plans to improve the quality of life for patients with multiple sclerosis. Upon completion of this education activity, learners will gain insight into how to better care for their patients with multiple sclerosis.
Target Audience
Neurologists, and other healthcare professionals who care for patients with MS.
Learning Objectives
1. Discuss the pathophysiology of all forms of multiple sclerosis to make more effective treatment plans.
2. Analyze current and emerging clinical trial data for therapeutics in the treatment of multiple sclerosis.
3. Implement patient education and shared decision making into patient-specific treatment plans to improve the quality of life for patients with MS.
Faculty
Augusto Miravalle, MD
Associate Professor of Neurology
Associate Chair of Education
Chief, Multiple Sclerosis Division
University of Florida College of Medicine
Gainesville, Florida
Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Faculty | Relationship Identified With: |
| Augusto Miravalle, MD | Consultant/Advisor: Biogen; Genentech, Inc.; Genzyme Corporation Grant/Research Support: American Board of Psychiatry and Neurology, Inc.; American Academy of Neurology; Celgene Corporation; F. Hoffmann-La Roche Ltd; Novartis AG |
Planners, Managers, Reviewers
Timothy Hayes, MD, PhD; Emma Boring and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
Accreditation Statement
AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Financial Support
This activity has been supported by an independent educational grant from Celgene Corporation.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Celgene Corporation do not recommend the use of any agent outside of the labeled indications.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
2. Complete the Pre-Activity Questions
3. Read or Review the activity content.
4. Complete the Post-Activity Test Questions and Evaluation.
5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.
CE Inquiries/Special Needs
For all CME inquiries or special needs, please contact [email protected].
